Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae.
Schuster M, Brabet E, Oi KK, Desjonquères N, Moehle K, Le Poupon K, Hell S, Gable S, Rithié V, Dillinger S, Zbinden P, Luther A, Li C, Stiegeler S, D'Arco C, Locher H, Remus T, DiMaio S, Motta P, Wach A, Jung F, Upert G, Obrecht D, Benghezal M, Zerbe O. Schuster M, et al. Among authors: zbinden p. Sci Adv. 2023 May 24;9(21):eadg3683. doi: 10.1126/sciadv.adg3683. Epub 2023 May 24. Sci Adv. 2023. PMID: 37224246 Free PMC article.
Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D. Luther A, et al. Among authors: zbinden p. Nature. 2019 Dec;576(7787):452-458. doi: 10.1038/s41586-019-1665-6. Epub 2019 Oct 23. Nature. 2019. PMID: 31645764
Author Correction: Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D. Luther A, et al. Among authors: zbinden p. Nature. 2019 Dec;576(7786):E5. doi: 10.1038/s41586-019-1810-2. Nature. 2019. PMID: 31758154
Frontier Between Cyclic Peptides and Macrocycles.
Ermert P, Luther A, Zbinden P, Obrecht D. Ermert P, et al. Among authors: zbinden p. Methods Mol Biol. 2019;2001:147-202. doi: 10.1007/978-1-4939-9504-2_9. Methods Mol Biol. 2019. PMID: 31134572 Review.
The evolution of microarrayed compound screening.
Hoever M, Zbinden P. Hoever M, et al. Among authors: zbinden p. Drug Discov Today. 2004 Apr 15;9(8):358-65. doi: 10.1016/S1359-6446(04)03037-5. Drug Discov Today. 2004. PMID: 15081963 Review.
Metabolism and disposition of imatinib mesylate in healthy volunteers.
Gschwind HP, Pfaar U, Waldmeier F, Zollinger M, Sayer C, Zbinden P, Hayes M, Pokorny R, Seiberling M, Ben-Am M, Peng B, Gross G. Gschwind HP, et al. Among authors: zbinden p. Drug Metab Dispos. 2005 Oct;33(10):1503-12. doi: 10.1124/dmd.105.004283. Epub 2005 Jul 8. Drug Metab Dispos. 2005. PMID: 16006570 Clinical Trial.
23 results